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Abstract
Background With the increasing use of high-resolution
ultrasound (US) examination, many breast carcinomas that
cannot be identiﬁed by mammography (MMG) alone have
been detected. Many of these carcinomas are ductal carci-
noma in situ (DCIS) and small-sized invasive carcinomas.
Until date, DCISs have often been described as palpable
masses with calciﬁcations on MMG, but what are the
characteristics of DCISs that are detectable by US alone?
Methods One hundred ﬁfty cases with DCIS that we
experienced at our clinic from 2003 to 2007 were classiﬁed
into 47 cases (echo group) diagnosed by US alone and 103
cases (MMG/PE group) diagnosed by MMG or clinically.
Results US ﬁndings of the echo group showed cystic or
solid lesions in 37 cases (79%). The mean age of the echo
group was signiﬁcantly higher than that of the MMG/PE
group (59.6 vs. 51.2 years; P\0.01). Tumor sizes detec-
ted by US were 5.7 ? 2.8 and 11.5 ? 10.8 mm (P\
0.001), respectively. The tumor sizes of the echo group
were, therefore, approximately half that of the MMG/PE
group. Extensive intraductal components were signiﬁcantly
fewer in the echo group, and tumor grades of the echo
group were signiﬁcantly low (Van Nuys classiﬁcation). In
the echo group, all cases with a tumor size \5 mm were
grade 1 by Van Nuys classiﬁcation. In addition, cases with
C5 mm tumor size had a signiﬁcantly lower tumor grade in
the echo group than in the MMG/PE group.
Conclusions Cystic or solid lesions accounted for
approximately 80% of US ﬁndings of DCISs detected by
US alone, and most were similar to benign forms. More-
over, most DCISs detected by US alone were localized and
of low grade (Van Nuys classiﬁcation).
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Introduction
The introduction of mammography (MMG) as an adjunct
in breast screening examination has increased the detection
frequency of ductal carcinoma in situ (DCIS). At the same
time, breast ultrasonography (US) examination in women
with dense breast tissue has led to the detection of breast
cancers that were not identiﬁed on MMG. The frequency of
breast cancses detected by US is approximately 0.3–0.4%.
US has been frequently reported to be more sensitive than
MMG [1–3], and many DCISs have been detected by US.
However, currently there is no deﬁnite opinion on US
ﬁndings of DCISs, which have been reported as irregular
masses, mammary duct ectasia [2, 4, 5], and benign cys-
toids [1, 5]. Furthermore, in these reports, many cases that
are detectable by MMG were included. We performed US
in all outpatients that visited our clinic, and those with
positive ﬁndings underwent detailed examination mainly
via aspiration biopsy cytology. As a result, we could detect
many DCISs by US alone [6]. In this study, we summarize
the features of DCISs detected by US alone based on US
and clinicopathological ﬁndings.
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From January 2003 to December 2007, we examined
35,886 women. Of those, 2,812 masses were sampled by
ultrasound-guided ﬁne-needle aspiration cytology. We
found 729 cases of primary breast cancers at our clinic, of
which 150 cases (20.6%) diagnosed with pathological
DCISs were included in this study. They were retrospec-
tively classiﬁed by one author into cases detected by US
alone (echo group) and cases detected by MMG or clinical
ﬁndings, such as palpable mass and abnormal nipple dis-
charge (MMG/PE group), and examined clinicopathologi-
cally. The following US devices were used: ALOKA-
SSD1000, ALOKA-SSD5000, TOSHIBA XARIO, and
APRIO. In all cases, MMG and US were performed
regardless of age. Cases with shape irregularities, internal
echo irregularities, segmental and solitary cystic lesions in
the elderly, etc., on US examination were examined in
detail [6] regardless of tumor size. For cases that required
detailed examination and those in which lesions were
observed by US, aspiration biopsy cytology was performed
using a 23 G needle.When MMG revealed calciﬁcations
and the lesions could not be determined by US, mammo-
tome biopsy was performed. For pathological investigation,
the resected specimens were cleaved at 2–5-mm intervals,
and sections were prepared. For classiﬁcation of DCIS
histological subtypes, comedo necrosis of C50% of the
gross tumor was categorized as comedo type and the others
as non-comedo type. For the assessment of extensive
intraductal components, those located C2 cm from the
periphery of the main lesions recognized by US were
deﬁned as positive. For the pathological classiﬁcation of
DCIS, Van-Nuys classiﬁcation [7] was used. The US and
clinicopathological ﬁndings were statistically analyzed by
v
2 analysis and t test.
Results
US ﬁndings of DCIS cases
Based on US ﬁndings, DCIS was classiﬁed into cystic or
solid mass (56 cases, Fig. 1), ill-deﬁned hypoechoic mass
(34 cases, Fig. 2), microlobulated mass (22 cases, Fig. 3),
duct dilatation (7 cases, Fig. 4), and calciﬁcation (7 cases).
DCIS features were classiﬁed as follows: cystic or solid
mass (hypoechoic or solid mass with clear margins,
spherical in shape or up to 4 scant nicks), ill-deﬁned
hypoechoic mass (horned), microlobulated mass (mam-
mary duct appears dilated, inner structure with a hypo-
echoic pattern), duct dilatation (one mammary duct is
dilated), calciﬁcation (presence of echogenic spots that
appear to be calciﬁcations; however, background changes
of the mammary gland are not helpful).
US ﬁndings in echo and MMG/PE groups
Echo and MMG/PE groups consisted of 47 and 103
cases, respectively (Table 1). In the latter, 23 patients
could not be diagnosed by US. Thirty-seven patients
(79%) of the echo group had a cystic or solid mass,
whereas in the MMG/PE group, cystic or solid mass, ill-
deﬁned hypoechoic mass, microlobulated mass, and duct
dilatation comprised 18, 25, 20, and 6%, respectively
(P\0.001).
Characteristics of mass-forming types identiﬁed
by US in echo and MMG/PE groups
For cases with a cystic or solid and ill-deﬁned hypoechoic
masses, the shape, margin, echogenicity, echogeneity, and
Fig. 1 a Cystic or solid mass; b NG1
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123posterior phenomena were examined (Table 2). As a result,
ovoid and irregular shapes were frequently observed in the
echo and MMG/PE groups (P\0.001), respectively.
While margins in the echo group were circumscribed
(42%) and microlobulated (49%), those in the MMG/PE
group tended to be microlobulated and indistinct
Fig. 2 a Ill-deﬁned hypoechoic mass; b NG2
Fig. 3 a Microlobulated mass; b NG3
Fig. 4 a Duct dilatation; b NG1
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123(P\0.01). Homogeneous echogeneity was observed in
half of the cases of the echo group, while in 69% of the
MMG/PE group, heterogeneous echogeneity was observed.
In both groups, there were almost no cases with posterior
phenomena.
Clinicopathological examination in echo (47 cases)
and MMG/PE (103 cases) groups
Mean age of the echo and MMG/PE groups was 59.6 and
51.2 years, respectively; it was signiﬁcantly higher in the
echo group (P\0.01). In the MMG/PE group, 40 patients
(38.8%) had symptoms such as awareness of a lump and
bloody nipple discharge. On MMG, 87 cases (84.5%) were
of grade C3 or higher, and on US, similar ﬁndings were
seen in 88 cases (85.4%). Mean mass diameters of the echo
and MMG/PE groups were 5.7 ± 2.8 and 11.5 ± 10.8 mm
(P\0.001), respectively, i.e., the mean mass diameters of
the echo group were approximately half that of the MMG/
PE group. Furthermore, mass diameters of the MMG/PE
group varied in size. Extensive intraductal components
were observed in 19 (40.4%) and 82 (79.6%) cases,
respectively, and were signiﬁcantly less in the echo group.
While in the MMG/PE group, comedocarcinomas were
observed in 7 of 103 cases, in the echo group, they were
observed only in 1 of 47 cases. Only one case in each group
had grades 2 and 3 (Van Nuys classiﬁcation), and tumor
grades were signiﬁcantly lower than in the MMG/PE
group. Additionally, in comparison cases detected by
MMG alone (MMG group), extensive intraductal compo-
nets were signiﬁcantly fewer in the echo group, and tumor
grades of the echo group were signiﬁcantly low. The tumor
size of the MMG group was ductal spread (Table 3).
Clinicopathological ﬁndings classiﬁed based
on US tumor size
US tumor size was classiﬁed into\5 and C5 mm groups,
and pathological ﬁndings were examined (Table 4). In the
echo group, \5 mm tumors were observed in 29 cases
(61.7%) and C5 mm in 18 cases (38.3%). In the MMG/PE
group,\5 mm tumors were observed in 16 cases (15.7%)
and C5 mm in 64 cases (62.1%). An overall tumor size of
\5 mm were observed in 45 cases (30%). Tumor size was
not associated with the presence of extensive intraductal
components in both echo and MMG/PE groups. In the echo
group, all cases with tumor sizes \5 mm were grade 1
(Van Nuys classiﬁcation), indicating low tumor grades.
Moreover, in the MMG/PE group, cases with tumor sizes
\5 mm had signiﬁcantly lower tumor grades than those
with tumor sizes C5 mm. In the echo group, in cases with
Table 1 Ultrasound Findings of DCIS in echo group versus MMG/
PE group
Ultrasound Findings  Echo -group  (n=47)  MMG/PE-group (n=103)
Cystic or solid mass  37 17 * 
Ill-definded hypoechoic mass  8 28
Microlobulated mass  1  22
Duct dilatation lesion 1  6 
Calcification lesion  0  7 
not visuable  0  23
* P\0.001
Table 2 Ultrasound features of cystic or solid masses and ill-deﬁned
hypoechoic masses in the echo group versus MMG/PE group ultra-
sound features
Echo-group (n=45)  MMG/PE-group (n=45)
Shape
Ovoid 27  10  * 
Lobular 12  12
Irregular 6  23
Margin
Circumscribed 19  12  **
Microlobulated 22 15
Indistinct 4  18
Echogenicity
Hypoechoic 24  29  ***
Isoechoic 21  16
Echogeneity
    Heterogeneous  22  31  ***
Homogeneous 23  14
Posterior phenomena
Nil 41  42
Enhanced 4  3 
* P\0.001, ** P\0.01, *** P\0.1
Table 3 Clinico-pathological ﬁndings of DCIS
Echo-group MMG/PE-group    (MMG-group) 
(n=47) (n=103) (n=12)
age 59.6  ±1 1.0  51.2 ±  11.4***  (48.8±7.15) 
Self symptoms  +  0  40  (0)
- 47  63  (12) 
MMG Category  1.2  47  16  (0)
Category 3-5  0  87  (12) 
Echo *  no FE  0  15  (12) 
request FE  47  88  (0)
Tumor size (mm)  5.7 ± 2.8  11.5 ± 10.8 ****  (27.5± 28.9) 
ductal spread**  +  19  82 ****  (5) **** 
- 28  21  (7)
Histological subtype 
comedo 1  7  (0)
non-comedo 46  96  (12) 
Van Nuys  1  45  71 ****  (7) **** 
2 1  15  (5)
3 1  17  (0)
FE Further examination
* Authors’ classiﬁcation; ** ?: cases with ductal spread C2 cm;
*** P\0.01; **** P\0.001
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123tumor sizes C5 mm, tumor grades were lower than those in
the MMG/PE group.
Discussion
Through a wider use of MMG, the frequency of DCIS
detection is increasing [9–13]. While many DCISs are
detected through microcalciﬁcations [11–13], those
without calciﬁcations cannot be detected by MMG, and
6–23% DCIS are said to remain undetected [5, 11–15].
At the same time, by breast US, smaller breast carci-
nomas can be detected than by MMG alone, and a high
breast carcinoma detection rate (0.31–0.4%) has been
reported in which the frequency of DCISs was 11–14%
[1–3]. US, in particular, is believed to be useful for
detecting breast carcinomas in young people with dense
breast tissue [1–3]. However, as most DCISs detected by
US that have been reported so far were comedo type,
many of them were also observed as abnormal by MMG
and frequently accompanied by subjective symptoms [6,
12–14, 16]. We performed US in all outpatients that
visited our clinic, and those with positive ﬁndings
underwent detailed examination. As a result, many
DCISs without subjective symptoms could be detected
by US alone [7].
In this study, we examined 150 cases with DCIS using
US and retrospectively classiﬁed them into a cystic or solid
mass, ill-deﬁned hypoechoic mass, microlobulated mass,
duct dilatation, and calciﬁcation. Among these, in 37 (79%)
of 47 cases with US ﬁndings alone, a cystic or solid mass
was observed. Most were ovoid in shape, and the margins
were circumscribed or microlobulated, making it difﬁcult
to differentiate from benign lesions. Moreover, approxi-
mately half of these cases had heterogeneous internal
echoes.
Moon et al. [6] reported DCISs detected by US;
however, they performed US in subjects with dense
breast tissue and subjective symptoms, and almost all
cases had calciﬁcations. Thus, this study cannot be
compared with ours. Chen et al. [16] reported that non-
comedo type DCISs are characterized by irregular mar-
gins, a non-uniform internal echo texture, and an anter-
oposterior diameter/width ratio of C0.7; however, they
were all palpable lesions, 35% of which had calciﬁca-
tions, and thus, the ﬁndings of this study deviates from
our results. On the other hand, recent reports on high-
resolution US make it likely that DCISs that we classi-
ﬁed as cystic and solid lesions in this study correspond
to the solid and cystic lesions comprising single or
multiple hypoechoic masses described by Moon et al. [6]
and to ‘‘Apart from the small size of the nonpalpable
and mammographically occult lesions: complex cysts’’
described by Wolfgang [1]. However, these reports also
deal with non-palpable cystic or solid masses and DCISs
with shapes similar to that of benign lesions, and it is
not mentioned that 79% of ﬁndings accounted for masses
detected by US alone. US ﬁndings of DCISs manifesting
solid and cystic masses are characterized by those
observed in benign diseases, and it is difﬁcult to dif-
ferentiate DCIS detected by US alone from benign dis-
eases [1, 2, 6]. In the present study, there were many
cases in which it was difﬁcult to differentiate DCISs
from benign lesions based on shape, margins, etc., and it
appeared necessary to conduct detailed investigation
mainly via aspiration biopsy cytology.
In this study, mass diameters of the echo group were
half that of the MMG/PE group and consistent with those
in other reports [1, 17, 18]. Furthermore, localized lesions
with few extensive intraductal components were frequently
observed, and the Van Nuys classiﬁcation [8] tumor grades
of the echo group were signiﬁcantly low. In the echo group,
all cases with lesions of \5 mm were Van Nuys classiﬁ-
cation grade 1. Tumor grades were also signiﬁcantly low
compared to those of lesions C5 mm of the MMG/PE
group. In addition, comparison of cases with lesions
C5 mm in both groups showed that tumor grades of the
echo group were lower than those of the MMG/PE group.
This suggested that cases with lesions of \5m m
detected by US alone can be successfully treated by local
resection [19, 20]. The prospective study by ultrasound
ﬁndings will be necessary in the future. Determination of
the course of treatment of such lesions is a subject of future
investigation.
DCISs detected by US alone were of low tumor grades
when classiﬁed by Van Nuys classiﬁcation and were
characterized by frequent localized lesions with few
extensive intraductal components, suggesting the possibil-
ity of successful treatment by local resection.
Table 4 Clinico-pathological ﬁndings of DCIS between tumor
size(US)
Echo-group MMG/PE  -group 
Tumor  Size(US)          <5mm 5mm 5mm 5mm
(n= 29)  (n= 18)  (n= 16)  (n= 64)
Age  61 ±10.4  49.9 ±8.5  49 ±10.6  52.5 ±11.8 * 
Tumor size(mm)  3.9 ± 1.0  8.3± 3.5  4.0 ± 0.9  15.1 ± 13.4
ductal spread +  10    9  11 50 
- 20  8  5  14 
Histological 
subtype   comedo  0  1  0  7 
non-comedo 29  17  16  57 
Van Nuys 1 29  16  12  41  **
2 0  1    3  7 
3 0  1    1  16 
<
* P\0.005, ** P\0.05
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